Vitamin A [EPC]

Vitamin A [EPC] was reported 50872 times

Drugs of the Vitamin A [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 70 0.1048
1 SERONEGATIVE ARTHRITIS 90 0.0785
2 LUPUS VULGARIS 92 0.0730
3 RETINITIS 89 0.0515
4 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 100 0.0482
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 92 0.0459
6 DISLOCATION OF VERTEBRA 104 0.0456
7 MUSCLE CRAMP 52 0.0293
8 SWOLLEN JOINT COUNT INCREASED 82 0.0257
9 WALKING AID USER 163 0.0247
10 BONE EROSION 84 0.0237
11 HAEMORRHAGIC ANAEMIA 102 0.0232
12 NEPHROGENIC ANAEMIA 97 0.0209
13 RHEUMATIC FEVER 93 0.0208
14 SPONDYLITIS 64 0.0176
15 HYPERPARATHYROIDISM SECONDARY 43 0.0171
16 BLOOD TESTOSTERONE DECREASED 117 0.0171
17 SPINAL FUSION SURGERY 69 0.0170
18 WOUND INFECTION 184 0.0168
19 EXOSTOSIS 150 0.0164
20 RHEUMATOID FACTOR POSITIVE 87 0.0150
21 GRIP STRENGTH DECREASED 129 0.0146
22 INJECTION SITE PAPULE 67 0.0146
23 REBOUND ACID HYPERSECRETION 42 0.0139
24 RESPIRATORY TRACT INFECTION VIRAL 31 0.0133
25 MUSCLE INJURY 109 0.0131
26 DUODENAL ULCER PERFORATION 97 0.0130
27 PRE-EXISTING CONDITION IMPROVED 81 0.0130
28 HELICOBACTER INFECTION 131 0.0127
29 LOWER GASTROINTESTINAL HAEMORRHAGE 93 0.0126
30 LUPUS-LIKE SYNDROME 114 0.0126
31 JOINT DISLOCATION 130 0.0123
32 WOUND COMPLICATION 40 0.0116
33 SPINAL COLUMN STENOSIS 55 0.0116
34 HYPERCHOLESTEROLAEMIA 112 0.0116
35 BODY HEIGHT DECREASED 123 0.0115
36 FOOT DEFORMITY 124 0.0112
37 BREAST CANCER STAGE III 72 0.0111
38 VITAMIN D DECREASED 95 0.0111
39 SCIATICA 172 0.0108
40 FOLLICULITIS 113 0.0108
41 AUTOIMMUNE DISORDER 105 0.0108
42 DIFFICULTY IN WALKING 37 0.0107
43 FIBRIN D DIMER INCREASED 38 0.0107
44 JOINT RANGE OF MOTION DECREASED 143 0.0107
45 THROMBOPHLEBITIS SUPERFICIAL 32 0.0106
46 PEMPHIGUS 132 0.0105
47 ENDOMETRIOSIS 49 0.0103
48 RED BLOOD CELL SEDIMENTATION RATE INCREASED 113 0.0102
49 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 72 0.0100
50 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 64 0.0098
51 PRESCRIBED UNDERDOSE 192 0.0096
52 PERICARDITIS 161 0.0096
53 TENDON PAIN 72 0.0095
54 INITIAL INSOMNIA 96 0.0093
55 THERAPY CESSATION 479 0.0093
56 PRODUCT SUBSTITUTION ISSUE 532 0.0092
57 JOINT STIFFNESS 242 0.0092
58 INTENTIONAL DEVICE MISUSE 40 0.0091
59 BLOOD CALCIUM INCREASED 78 0.0089
60 FIBROMYALGIA 214 0.0088
61 FAECAL INCONTINENCE 42 0.0087
62 PHARYNGOLARYNGEAL PAIN 46 0.0086
63 SINUS HEADACHE 51 0.0086
64 HANGOVER 30 0.0085
65 GLOSSODYNIA 191 0.0085
66 WOUND 238 0.0085
67 MUSCLE FATIGUE 36 0.0085
68 SNORING 32 0.0085
69 MENISCUS INJURY 52 0.0084
70 GINGIVAL SWELLING 37 0.0084
71 LOCAL SWELLING 145 0.0083
72 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 45 0.0083
73 PROTEIN TOTAL DECREASED 31 0.0082
74 ONYCHOMYCOSIS 36 0.0082
75 PELVIC PAIN 149 0.0082
76 LACERATION 77 0.0082
77 HIP ARTHROPLASTY 125 0.0082
78 INCREASED TENDENCY TO BRUISE 75 0.0081
79 DYSMENORRHOEA 108 0.0081
80 PROSTATOMEGALY 32 0.0081
81 BLOOD IRON DECREASED 96 0.0081
82 HAND DEFORMITY 106 0.0081
83 SPINAL OSTEOARTHRITIS 71 0.0081
84 SINUS CONGESTION 108 0.0080
85 IRRITABLE BOWEL SYNDROME 171 0.0080
86 UPPER RESPIRATORY TRACT INFECTION 368 0.0080
87 STOMACH DISCOMFORT 41 0.0079
88 PARANASAL SINUS HYPERSECRETION 30 0.0079
89 FULL BLOOD COUNT DECREASED 157 0.0078
90 MIDDLE INSOMNIA 145 0.0078
91 MENORRHAGIA 152 0.0077
92 PRODUCT FORMULATION ISSUE 51 0.0077
93 OSTEOPOROSIS 317 0.0077
94 LOWER LIMB FRACTURE 148 0.0077
95 PARANASAL SINUS DISCOMFORT 29 0.0077
96 SKIN TIGHTNESS 36 0.0076
97 INJECTION SITE NODULE 84 0.0076
98 EAR INFECTION 203 0.0076
99 OSTEOARTHRITIS 323 0.0076
100 CHOLECYSTITIS CHRONIC 51 0.0076
101 SMALL INTESTINAL OBSTRUCTION 93 0.0075
102 DECREASED INTEREST 44 0.0075
103 END STAGE RENAL DISEASE 136 0.0074
104 ATELECTASIS 72 0.0074
105 PRESCRIBED OVERDOSE 144 0.0074
106 TYPE 2 DIABETES MELLITUS 250 0.0074
107 PERONEAL NERVE PALSY 42 0.0074
108 THERAPY CHANGE 72 0.0073
109 TENDERNESS 76 0.0073
110 HAEMATOCRIT DECREASED 144 0.0073
111 AMMONIA INCREASED 37 0.0072
112 INCREASED UPPER AIRWAY SECRETION 37 0.0072
113 SINUSITIS 736 0.0072
114 VITAMIN D DEFICIENCY 70 0.0072
115 INTERNATIONAL NORMALISED RATIO DECREASED 29 0.0072
116 UPPER-AIRWAY COUGH SYNDROME 59 0.0072
117 ANORECTAL DISCOMFORT 38 0.0071
118 CHAPPED LIPS 31 0.0071
119 BALANCE DISORDER 617 0.0071
120 HOSPICE CARE 70 0.0071
121 IMPAIRED HEALING 232 0.0071
122 IMPAIRED DRIVING ABILITY 80 0.0070
123 MUSCULOSKELETAL PAIN 368 0.0070
124 VAGINAL DISCHARGE 71 0.0070
125 MICTURITION URGENCY 80 0.0070
126 SKIN ABRASION 33 0.0070
127 HEPATIC CIRRHOSIS 131 0.0070
128 TRICUSPID VALVE INCOMPETENCE 55 0.0069
129 ACTIVITIES OF DAILY LIVING IMPAIRED 137 0.0069
130 BLOOD CHOLESTEROL INCREASED 322 0.0069
131 BREAST TENDERNESS 52 0.0069
132 PULMONARY FIBROSIS 132 0.0069
133 ROSACEA 32 0.0069
134 COAGULOPATHY 114 0.0068
135 MUSCLE SPASTICITY 84 0.0068
136 BLOOD MAGNESIUM DECREASED 59 0.0068
137 URINE ODOUR ABNORMAL 40 0.0068
138 ENERGY INCREASED 40 0.0068
139 MENSTRUAL DISORDER 56 0.0068
140 NAIL DISORDER 59 0.0067
141 SKIN WARM 39 0.0067
142 INTERVERTEBRAL DISC DEGENERATION 62 0.0067
143 ROTATOR CUFF SYNDROME 86 0.0067
144 TENDONITIS 103 0.0066
145 SCREAMING 42 0.0066
146 LIVER FUNCTION TEST INCREASED 141 0.0066
147 NERVE INJURY 73 0.0066
148 FEELING JITTERY 125 0.0066
149 HAEMORRHOIDAL HAEMORRHAGE 32 0.0065
150 BLOOD POTASSIUM DECREASED 197 0.0065
151 RESTLESS LEGS SYNDROME 119 0.0065
152 METRORRHAGIA 111 0.0065
153 TEMPERATURE INTOLERANCE 67 0.0065
154 RASH PAPULAR 145 0.0065
155 MUSCLE TIGHTNESS 104 0.0064
156 MUSCULAR WEAKNESS 729 0.0064
157 FLATULENCE 363 0.0064
158 SCAB 73 0.0064
159 FLUID OVERLOAD 93 0.0064
160 DRY MOUTH 518 0.0064
161 BLOOD THYROID STIMULATING HORMONE DECREASED 29 0.0064
162 PANIC REACTION 46 0.0064
163 VAGINAL HAEMORRHAGE 276 0.0064
164 FAILURE TO THRIVE 33 0.0063
165 HAND FRACTURE 45 0.0063
166 BURSITIS 77 0.0063
167 CLOSTRIDIUM DIFFICILE COLITIS 67 0.0063
168 PSORIATIC ARTHROPATHY 256 0.0063
169 SQUAMOUS CELL CARCINOMA OF SKIN 38 0.0063
170 UTERINE LEIOMYOMA 46 0.0063
171 SLEEP APNOEA SYNDROME 120 0.0063
172 INJECTION SITE HAEMORRHAGE 500 0.0063
173 SOMNAMBULISM 41 0.0062
174 CONTUSION 601 0.0062
175 MUSCLE STRAIN 54 0.0062
176 HUMERUS FRACTURE 30 0.0062
177 PROCTALGIA 40 0.0062
178 GALLBLADDER DISORDER 111 0.0062
179 KNEE ARTHROPLASTY 130 0.0062
180 HYPERKERATOSIS 34 0.0062
181 BRONCHITIS 456 0.0062
182 COMPRESSION FRACTURE 33 0.0062
183 GAIT INABILITY 205 0.0061
184 OSTEOPENIA 93 0.0061
185 PRURITUS GENERALISED 132 0.0061
186 BUNDLE BRANCH BLOCK RIGHT 28 0.0061
187 MUSCULOSKELETAL STIFFNESS 534 0.0061
188 CLOSTRIDIUM DIFFICILE INFECTION 133 0.0061
189 INJECTION SITE BRUISING 486 0.0061
190 GAIT DISTURBANCE 1165 0.0061
191 HYPERAESTHESIA 50 0.0061
192 TENDON RUPTURE 75 0.0061
193 NIGHT SWEATS 195 0.0060
194 MOOD SWINGS 192 0.0060
195 BLOOD URINE PRESENT 114 0.0060
196 BREAST PAIN 64 0.0060
197 MENSTRUATION DELAYED 65 0.0060
198 DEFAECATION URGENCY 42 0.0060
199 CORONARY ARTERY OCCLUSION 82 0.0060
200 BACK INJURY 65 0.0060
201 MOBILITY DECREASED 429 0.0060
202 HYPOAESTHESIA ORAL 90 0.0060
203 HOT FLUSH 448 0.0059
204 BLOOD COUNT ABNORMAL 90 0.0059
205 MUSCLE ATROPHY 75 0.0059
206 OEDEMA 321 0.0059
207 EXERCISE TOLERANCE DECREASED 34 0.0059
208 VENTRICULAR EXTRASYSTOLES 61 0.0059
209 POOR QUALITY DRUG ADMINISTERED 38 0.0059
210 MULTIPLE ALLERGIES 46 0.0059
211 HYPOAESTHESIA 877 0.0059
212 PHOTOPSIA 37 0.0058
213 WRIST FRACTURE 70 0.0058
214 SINUS DISORDER 115 0.0058
215 SPINAL COMPRESSION FRACTURE 48 0.0058
216 TOOTH FRACTURE 64 0.0058
217 THERAPEUTIC RESPONSE UNEXPECTED 260 0.0058
218 SEASONAL ALLERGY 82 0.0058
219 GINGIVAL PAIN 46 0.0058
220 UPPER GASTROINTESTINAL HAEMORRHAGE 97 0.0058
221 PANIC ATTACK 210 0.0058
222 EAR PAIN 112 0.0058
223 GASTROOESOPHAGEAL REFLUX DISEASE 463 0.0057
224 BRUXISM 31 0.0057
225 SKIN ATROPHY 33 0.0057
226 CHEILITIS 31 0.0057
227 CARDIAC FLUTTER 37 0.0057
228 CHRONIC KIDNEY DISEASE 434 0.0057
229 BONE DISORDER 104 0.0057
230 DRY THROAT 58 0.0057
231 TOOTH ABSCESS 58 0.0057
232 TOOTH INFECTION 75 0.0057
233 LOW DENSITY LIPOPROTEIN INCREASED 44 0.0057
234 DIZZINESS POSTURAL 55 0.0057
235 ARTHROPOD BITE 42 0.0057
236 MUSCLE SPASMS 1037 0.0056
237 SCOLIOSIS 35 0.0056
238 GASTROENTERITIS VIRAL 102 0.0056
239 NERVE COMPRESSION 52 0.0056
240 FREQUENT BOWEL MOVEMENTS 152 0.0056
241 INSOMNIA 1495 0.0056
242 OEDEMA PERIPHERAL 682 0.0056
243 VIRAL INFECTION 186 0.0056
244 POLLAKIURIA 233 0.0056
245 DEEP VEIN THROMBOSIS 363 0.0056
246 VISUAL DISTURBANCE 32 0.0056
247 DYSPEPSIA 548 0.0056
248 PAROSMIA 42 0.0056
249 LIGAMENT SPRAIN 55 0.0056
250 HIATUS HERNIA 72 0.0056
251 BLEPHAROSPASM 35 0.0056
252 DYSPNOEA EXERTIONAL 209 0.0055
253 FLUSHING 564 0.0055
254 BLOOD ALBUMIN DECREASED 44 0.0055
255 STOMATITIS 336 0.0055
256 ARTHRITIS 435 0.0055
257 TINNITUS 254 0.0055
258 LABORATORY TEST ABNORMAL 163 0.0055
259 FEELING DRUNK 41 0.0055
260 ABASIA 136 0.0055
261 FAECES SOFT 40 0.0055
262 DYSGEUSIA 408 0.0055
263 SYNOVITIS 99 0.0055
264 DIVERTICULUM 39 0.0055
265 AMNESIA 357 0.0055
266 ERUCTATION 106 0.0055
267 HYPERSOMNIA 157 0.0055
268 HYPOPHAGIA 140 0.0055
269 RESPIRATORY TRACT CONGESTION 87 0.0055
270 PERIPHERAL COLDNESS 75 0.0055
271 LIVER INJURY 134 0.0055
272 CRYING 198 0.0054
273 NECK PAIN 304 0.0054
274 NOCTURIA 66 0.0054
275 NASAL DRYNESS 34 0.0054
276 NASAL DISCOMFORT 43 0.0054
277 FEELING HOT 332 0.0054
278 AGEUSIA 135 0.0054
279 RECTAL HAEMORRHAGE 232 0.0054
280 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 383 0.0054
281 GASTROINTESTINAL HAEMORRHAGE 449 0.0054
282 WHEEZING 318 0.0054
283 CHROMATURIA 121 0.0054
284 PARAESTHESIA 843 0.0054
285 CELLULITIS 270 0.0054
286 RASH PRURITIC 290 0.0053
287 PRODUCT DOSE OMISSION 349 0.0053
288 INJECTION SITE PRURITUS 358 0.0053
289 DYSPHONIA 312 0.0053
290 PAIN IN JAW 151 0.0053
291 RASH GENERALISED 138 0.0053
292 DEPRESSION 1210 0.0053
293 PAIN OF SKIN 143 0.0053
294 ROAD TRAFFIC ACCIDENT 222 0.0053
295 TOOTHACHE 96 0.0053
296 NASAL CONGESTION 311 0.0053
297 VITREOUS FLOATERS 52 0.0053
298 RENAL CYST 42 0.0053
299 CARPAL TUNNEL SYNDROME 74 0.0053
300 RED BLOOD CELL COUNT DECREASED 151 0.0053
301 FALL 1754 0.0053
302 URINE OUTPUT DECREASED 46 0.0053
303 EAR DISCOMFORT 54 0.0053
304 PERIPHERAL SWELLING 810 0.0053
305 SCAR 90 0.0053
306 DRUG EFFECT DECREASED 283 0.0052
307 ACUTE RESPIRATORY FAILURE 101 0.0052
308 DENTAL CARIES 58 0.0052
309 GROIN PAIN 46 0.0052
310 BLADDER DISORDER 52 0.0052
311 BOWEL MOVEMENT IRREGULARITY 40 0.0052
312 BREAST MASS 35 0.0052
313 DISTURBANCE IN ATTENTION 281 0.0052
314 DYSSTASIA 152 0.0052
315 MOUTH SWELLING 30 0.0052
316 ACNE 393 0.0052
317 HEART RATE IRREGULAR 117 0.0052
318 PULMONARY HYPERTENSION 107 0.0051
319 DRUG DOSE OMISSION 849 0.0051
320 WEIGHT DECREASED 1432 0.0051
321 BASAL CELL CARCINOMA 80 0.0051
322 HYPOVOLAEMIA 30 0.0051
323 RHINORRHOEA 331 0.0051
324 MEMORY IMPAIRMENT 703 0.0051
325 OROPHARYNGEAL PAIN 473 0.0051
326 RIB FRACTURE 105 0.0051
327 MUSCULOSKELETAL CHEST PAIN 79 0.0051
328 FEELING ABNORMAL 1222 0.0051
329 INJECTION SITE INDURATION 66 0.0051
330 ABDOMINAL DISTENSION 531 0.0051
331 TOOTH DISORDER 113 0.0051
332 UNEVALUABLE EVENT 384 0.0051
333 BLISTER 285 0.0051
334 ABNORMAL DREAMS 140 0.0051
335 BLOOD CALCIUM DECREASED 57 0.0051
336 HIP FRACTURE 163 0.0051
337 TRANSFUSION 53 0.0051
338 INJECTION SITE WARMTH 104 0.0051
339 INJECTION SITE ERYTHEMA 627 0.0050
340 INTERNATIONAL NORMALISED RATIO INCREASED 144 0.0050
341 ANOREXIA 65 0.0050
342 BACK DISORDER 82 0.0050
343 MENTAL STATUS CHANGES 140 0.0050
344 CARDIAC PACEMAKER INSERTION 30 0.0050
345 MUSCLE TWITCHING 116 0.0050
346 INTERVERTEBRAL DISC PROTRUSION 110 0.0050
347 DIARRHOEA HAEMORRHAGIC 47 0.0050
348 HAEMOGLOBIN DECREASED 515 0.0050
349 ATRIAL FLUTTER 40 0.0050
350 SLUGGISHNESS 51 0.0050
351 BLOOD THYROID STIMULATING HORMONE INCREASED 46 0.0050
352 BLOOD DISORDER 40 0.0050
353 WRONG TECHNIQUE IN DRUG USAGE PROCESS 181 0.0050
354 ASTHENIA 1871 0.0050
355 FATIGUE 3874 0.0050
356 JOINT SWELLING 600 0.0050
357 ORAL PAIN 111 0.0050
358 RASH MACULAR 173 0.0049
359 DIZZINESS 2464 0.0049
360 ORAL CANDIDIASIS 65 0.0049
361 NEUROPATHY PERIPHERAL 469 0.0049
362 BACK PAIN 1144 0.0049
363 FURUNCLE 39 0.0049
364 INCONTINENCE 52 0.0049
365 DECUBITUS ULCER 40 0.0049
366 LARGE INTESTINE POLYP 34 0.0049
367 CONSTIPATION 1070 0.0049
368 DISABILITY 97 0.0049
369 GLUCOSE TOLERANCE IMPAIRED 29 0.0049
370 FISTULA 55 0.0049
371 POLYP 32 0.0049
372 PELVIC FRACTURE 38 0.0049
373 ARTHROPATHY 271 0.0049
374 IRON DEFICIENCY ANAEMIA 45 0.0049
375 HICCUPS 40 0.0049
376 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 234 0.0049
377 BURNING SENSATION 341 0.0049
378 DEHYDRATION 648 0.0049
379 PAIN IN EXTREMITY 1429 0.0048
380 ABNORMAL LOSS OF WEIGHT 33 0.0048
381 INJURY 339 0.0048
382 ANXIETY 1372 0.0048
383 FEELING COLD 134 0.0048
384 DYSURIA 177 0.0048
385 HEAD DISCOMFORT 85 0.0048
386 FLANK PAIN 45 0.0048
387 DIVERTICULITIS 133 0.0048
388 INJECTION SITE PAIN 1471 0.0048
389 COELIAC DISEASE 47 0.0048
390 STAPHYLOCOCCAL INFECTION 158 0.0048
391 NERVOUSNESS 250 0.0048
392 POOR QUALITY SLEEP 103 0.0048
393 FLUID RETENTION 243 0.0048
394 JOINT INJURY 102 0.0048
395 LYMPHOEDEMA 33 0.0048
396 PRESYNCOPE 116 0.0048
397 SNEEZING 107 0.0048
398 NASOPHARYNGITIS 879 0.0048
399 INFLUENZA LIKE ILLNESS 392 0.0048
400 URINARY INCONTINENCE 141 0.0048
401 DELIRIUM 165 0.0047
402 MYALGIA 808 0.0047
403 ORAL DISCOMFORT 66 0.0047
404 CONFUSIONAL STATE 766 0.0047
405 CHILLS 555 0.0047
406 PHOTOPHOBIA 89 0.0047
407 TROPONIN INCREASED 36 0.0047
408 ANGER 160 0.0047
409 APHONIA 66 0.0047
410 BLOOD SODIUM DECREASED 89 0.0047
411 CHEST PAIN 874 0.0047
412 PARAESTHESIA ORAL 68 0.0047
413 LETHARGY 271 0.0047
414 HAIR TEXTURE ABNORMAL 63 0.0047
415 HEPATIC ENZYME INCREASED 321 0.0047
416 MUSCULOSKELETAL DISCOMFORT 81 0.0047
417 FAECES DISCOLOURED 102 0.0047
418 MACULAR DEGENERATION 56 0.0047
419 PALPITATIONS 549 0.0047
420 HYDRONEPHROSIS 35 0.0047
421 SQUAMOUS CELL CARCINOMA 44 0.0047
422 THROAT IRRITATION 209 0.0047
423 DECREASED APPETITE 1081 0.0046
424 CONCUSSION 36 0.0046
425 NEURALGIA 113 0.0046
426 RETCHING 99 0.0046
427 BLOOD TRIGLYCERIDES INCREASED 82 0.0046
428 IMPAIRED WORK ABILITY 99 0.0046
429 INJECTION SITE VESICLES 28 0.0046
430 DRUG EFFECT INCOMPLETE 168 0.0046
431 POST-TRAUMATIC STRESS DISORDER 31 0.0046
432 ABDOMINAL PAIN 1075 0.0046
433 PULMONARY EMBOLISM 439 0.0046
434 DIARRHOEA 2973 0.0046
435 TENDON DISORDER 30 0.0046
436 AORTIC ANEURYSM 35 0.0046
437 FORMICATION 32 0.0046
438 URINARY TRACT INFECTION 784 0.0046
439 COLD SWEAT 81 0.0046
440 CYST 57 0.0046
441 ABDOMINAL DISCOMFORT 769 0.0046
442 CHOLELITHIASIS 150 0.0046
443 DELUSION 71 0.0046
444 MUSCLE DISORDER 37 0.0046
445 INJECTION SITE URTICARIA 112 0.0046
446 DYSGRAPHIA 30 0.0045
447 PHARYNGEAL OEDEMA 70 0.0045
448 SKIN INFECTION 51 0.0045
449 HYPOKINESIA 66 0.0045
450 HYPOXIA 160 0.0045
451 FOOT FRACTURE 86 0.0045
452 ENTERITIS 29 0.0045
453 CHEST DISCOMFORT 464 0.0045
454 APATHY 66 0.0045
455 CYSTITIS 144 0.0045
456 ANKLE FRACTURE 70 0.0045
457 ABNORMAL FAECES 37 0.0045
458 MOTOR DYSFUNCTION 46 0.0045
459 ONYCHOCLASIS 31 0.0045
460 RESPIRATION ABNORMAL 31 0.0045
461 MIGRAINE 429 0.0045
462 ATRIAL FIBRILLATION 437 0.0045
463 RENAL TUBULAR NECROSIS 44 0.0045
464 PHOTOSENSITIVITY REACTION 74 0.0045
465 C-REACTIVE PROTEIN INCREASED 163 0.0045
466 ARTHRALGIA 1861 0.0045
467 WEIGHT INCREASED 1000 0.0045
468 INJECTION SITE EXTRAVASATION 55 0.0045
469 MENTAL IMPAIRMENT 108 0.0045
470 GASTROINTESTINAL PAIN 49 0.0044
471 SWELLING FACE 290 0.0044
472 TREMOR 739 0.0044
473 NODULE 58 0.0044
474 THROAT TIGHTNESS 120 0.0044
475 PHARYNGITIS STREPTOCOCCAL 48 0.0044
476 SLEEP DISORDER 313 0.0044
477 SKIN BURNING SENSATION 317 0.0044
478 RIGHT VENTRICULAR FAILURE 31 0.0044
479 RENAL FAILURE CHRONIC 34 0.0044
480 WHITE BLOOD CELL COUNT DECREASED 479 0.0044
481 ALOPECIA 866 0.0044
482 PLASMA CELL MYELOMA 172 0.0044
483 LIMB DISCOMFORT 136 0.0044
484 NIGHTMARE 152 0.0044
485 DRY SKIN 585 0.0044
486 CHOLECYSTECTOMY 50 0.0044
487 HEADACHE 2742 0.0044
488 THERMAL BURN 31 0.0044
489 GASTRIC ULCER 83 0.0044
490 THIRST 78 0.0044
491 MOOD ALTERED 119 0.0044
492 HEAD INJURY 138 0.0044
493 INJECTION SITE MASS 161 0.0043
494 BONE PAIN 255 0.0043
495 RASH ERYTHEMATOUS 208 0.0043
496 PARANOIA 75 0.0043
497 SKIN IRRITATION 199 0.0043
498 SKIN MASS 29 0.0043
499 GASTROINTESTINAL INFLAMMATION 34 0.0043
500 EYE INFECTION 49 0.0043
501 PLEURAL EFFUSION 264 0.0043
502 INCORRECT DRUG ADMINISTRATION DURATION 122 0.0043
503 BEDRIDDEN 57 0.0043
504 LOSS OF LIBIDO 39 0.0043
505 NAUSEA 3428 0.0043
506 MITRAL VALVE INCOMPETENCE 49 0.0043
507 PULMONARY CONGESTION 57 0.0043
508 EPISTAXIS 323 0.0043
509 UPPER LIMB FRACTURE 86 0.0043
510 APPLICATION SITE PAIN 95 0.0043
511 RENAL FAILURE ACUTE 183 0.0043
512 COORDINATION ABNORMAL 60 0.0043
513 HEART RATE INCREASED 426 0.0043
514 SENSORY DISTURBANCE 69 0.0043
515 PSORIASIS 561 0.0043
516 LIP DRY 39 0.0043
517 HYPERCALCAEMIA 53 0.0043
518 SUNBURN 32 0.0043
519 TONGUE DISORDER 31 0.0043
520 FEAR 115 0.0043
521 DRUG ADMINISTERED AT INAPPROPRIATE SITE 45 0.0043
522 FUNGAL INFECTION 142 0.0043
523 HAEMORRHOIDS 83 0.0043
524 ABDOMINAL PAIN UPPER 875 0.0042
525 SKIN EXFOLIATION 358 0.0042
526 TRANSIENT ISCHAEMIC ATTACK 143 0.0042
527 OBSESSIVE-COMPULSIVE DISORDER 34 0.0042
528 LIP SWELLING 141 0.0042
529 ECCHYMOSIS 29 0.0042
530 SYSTEMIC LUPUS ERYTHEMATOSUS 150 0.0042
531 EYE SWELLING 157 0.0042
532 DISORIENTATION 167 0.0042
533 DISCOMFORT 257 0.0042
534 SWELLING 394 0.0042
535 MALNUTRITION 47 0.0042
536 RECALLED PRODUCT ADMINISTERED 40 0.0042
537 URTICARIA 702 0.0042
538 HAIR GROWTH ABNORMAL 29 0.0042
539 HYPERLIPIDAEMIA 50 0.0042
540 GOUT 75 0.0042
541 HUNGER 58 0.0042
542 MENSTRUATION IRREGULAR 111 0.0041
543 PULMONARY ARTERIAL HYPERTENSION 60 0.0041
544 COUGH 1157 0.0041
545 SKIN DISCOLOURATION 189 0.0041
546 OVARIAN CYST 41 0.0041
547 VISION BLURRED 563 0.0041
548 PNEUMONIA 1326 0.0041
549 HAEMATOCHEZIA 226 0.0041
550 HYPERHIDROSIS 527 0.0041
551 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 213 0.0041
552 THINKING ABNORMAL 76 0.0041
553 ANOSMIA 59 0.0041
554 SUPRAVENTRICULAR TACHYCARDIA 39 0.0041
555 RENAL PAIN 43 0.0041
556 SUBDURAL HAEMATOMA 58 0.0040
557 EYE HAEMORRHAGE 54 0.0040
558 CARDIAC MURMUR 35 0.0040
559 BACTERAEMIA 48 0.0040
560 APPLICATION SITE ERYTHEMA 106 0.0040
561 LYMPHADENOPATHY 143 0.0040
562 SENSATION OF FOREIGN BODY 34 0.0040
563 NEPHROLITHIASIS 185 0.0040
564 OSTEOMYELITIS 73 0.0040
565 MULTIPLE SCLEROSIS RELAPSE 276 0.0040
566 QUALITY OF LIFE DECREASED 54 0.0040
567 INJECTION SITE DISCOLOURATION 50 0.0040
568 ANAEMIA 762 0.0040
569 BLOOD PRESSURE INCREASED 610 0.0040
570 CATARACT 237 0.0040
571 KIDNEY INFECTION 78 0.0040
572 RHINITIS 32 0.0040
573 BACTERIAL INFECTION 74 0.0040
574 LUNG INFILTRATION 35 0.0040
575 ATAXIA 47 0.0040
576 PRODUCTIVE COUGH 189 0.0040
577 POST PROCEDURAL COMPLICATION 76 0.0040
578 ABDOMINAL PAIN LOWER 100 0.0040
579 INJECTION SITE RASH 121 0.0039
580 CARDIAC FAILURE CONGESTIVE 315 0.0039
581 RETINAL DETACHMENT 36 0.0039
582 BLOOD ALKALINE PHOSPHATASE INCREASED 97 0.0039
583 VERTIGO 238 0.0039
584 PULMONARY MASS 58 0.0039
585 SPINAL FRACTURE 78 0.0039
586 FOOD ALLERGY 30 0.0039
587 HALLUCINATION, VISUAL 82 0.0039
588 BLOOD POTASSIUM INCREASED 63 0.0039
589 RESPIRATORY TRACT INFECTION 101 0.0039
590 MADAROSIS 45 0.0039
591 VISUAL IMPAIRMENT 480 0.0039
592 BODY TEMPERATURE INCREASED 79 0.0039
593 SENSORY LOSS 31 0.0038
594 ORTHOSTATIC HYPOTENSION 67 0.0038
595 STENT PLACEMENT 31 0.0038
596 ASPIRATION 42 0.0038
597 DYSPNOEA 2170 0.0038
598 DERMATITIS 80 0.0038
599 IRRITABILITY 229 0.0038
600 DRY EYE 190 0.0038
601 LUNG INFECTION 59 0.0038
602 SCRATCH 40 0.0038
603 MULTIPLE SCLEROSIS 181 0.0038
604 DEPRESSED MOOD 200 0.0038
605 SPEECH DISORDER 198 0.0038
606 ERECTILE DYSFUNCTION 97 0.0038
607 APHASIA 114 0.0038
608 LOCALISED INFECTION 91 0.0038
609 BLOOD UREA INCREASED 63 0.0038
610 ERYTHEMA 770 0.0037
611 COLITIS 142 0.0037
612 INJECTION SITE SWELLING 287 0.0037
613 COGNITIVE DISORDER 174 0.0037
614 PRODUCT ODOUR ABNORMAL 39 0.0037
615 PERICARDIAL EFFUSION 86 0.0037
616 RASH 1618 0.0037
617 HERPES ZOSTER 213 0.0037
618 PYREXIA 1280 0.0037
619 POST PROCEDURAL INFECTION 30 0.0037
620 BIPOLAR DISORDER 40 0.0037
621 SECRETION DISCHARGE 46 0.0037
622 SPLENOMEGALY 43 0.0037
623 BLOOD BILIRUBIN INCREASED 99 0.0037
624 OROPHARYNGEAL DISCOMFORT 33 0.0036
625 PLATELET COUNT DECREASED 389 0.0036
626 HALLUCINATION 275 0.0036
627 RENAL FAILURE 483 0.0036
628 ASPARTATE AMINOTRANSFERASE INCREASED 193 0.0036
629 SKIN FISSURES 71 0.0036
630 HYPERSENSITIVITY 674 0.0036
631 RHEUMATOID ARTHRITIS 412 0.0036
632 GASTRIC DISORDER 124 0.0036
633 CHOLECYSTITIS 43 0.0036
634 MANIA 59 0.0036
635 SOMNOLENCE 721 0.0036
636 DIPLOPIA 93 0.0036
637 LIVER FUNCTION TEST ABNORMAL 104 0.0036
638 EMPHYSEMA 36 0.0036
639 ELECTROCARDIOGRAM ABNORMAL 28 0.0036
640 IMMUNE SYSTEM DISORDER 47 0.0036
641 ANAL INCONTINENCE 32 0.0036
642 SKIN DISORDER 118 0.0035
643 HEPATIC ENCEPHALOPATHY 33 0.0035
644 DECREASED ACTIVITY 38 0.0035
645 CARDIOMYOPATHY 52 0.0035
646 DERMATITIS CONTACT 40 0.0035
647 PRURITUS 1347 0.0035
648 CARDIOMEGALY 43 0.0035
649 SKIN LACERATION 38 0.0035
650 VOMITING 1642 0.0035
651 EYE PAIN 197 0.0035
652 SKIN HYPERPIGMENTATION 30 0.0035
653 SWOLLEN TONGUE 109 0.0035
654 HYPERTENSION 737 0.0035
655 URINARY RETENTION 116 0.0035
656 HYPOTHYROIDISM 111 0.0035
657 VISUAL ACUITY REDUCED 115 0.0035
658 GASTROINTESTINAL INFECTION 31 0.0035
659 MOVEMENT DISORDER 111 0.0035
660 SKIN SWELLING 30 0.0035
661 TACHYCARDIA 307 0.0035
662 DYSARTHRIA 130 0.0035
663 TASTE DISORDER 70 0.0034
664 PRODUCT QUALITY ISSUE 468 0.0034
665 INJECTION SITE REACTION 237 0.0034
666 SKIN ULCER 89 0.0034
667 LACRIMATION INCREASED 104 0.0034
668 PAIN 2110 0.0034
669 MASS 48 0.0034
670 PHARMACEUTICAL PRODUCT COMPLAINT 89 0.0034
671 BLOOD PRESSURE FLUCTUATION 82 0.0034
672 INTERNAL HAEMORRHAGE 39 0.0034
673 HAEMOPTYSIS 95 0.0034
674 APPLICATION SITE PRURITUS 77 0.0034
675 WHITE BLOOD CELL COUNT INCREASED 130 0.0034
676 INFLUENZA 377 0.0034
677 HAIR COLOUR CHANGES 42 0.0034
678 GINGIVAL BLEEDING 46 0.0034
679 HERNIA 65 0.0034
680 HYSTERECTOMY 29 0.0033
681 WEIGHT FLUCTUATION 35 0.0033
682 PROSTATIC SPECIFIC ANTIGEN INCREASED 46 0.0033
683 BLINDNESS UNILATERAL 47 0.0033
684 SUICIDAL IDEATION 305 0.0033
685 INFUSION SITE ERYTHEMA 28 0.0033
686 HAEMATURIA 113 0.0033
687 INTESTINAL OBSTRUCTION 124 0.0033
688 EATING DISORDER 70 0.0033
689 MALIGNANT MELANOMA 44 0.0033
690 CENTRAL NERVOUS SYSTEM LESION 45 0.0033
691 COLITIS ULCERATIVE 146 0.0033
692 DYSPHAGIA 310 0.0033
693 THROMBOSIS 262 0.0033
694 DRUG-INDUCED LIVER INJURY 102 0.0032
695 PRODUCT TASTE ABNORMAL 44 0.0032
696 INCREASED APPETITE 62 0.0032
697 THYROID DISORDER 50 0.0032
698 DEVICE DISLOCATION 141 0.0032
699 MYOSITIS 29 0.0032
700 PERSONALITY CHANGE 30 0.0032
701 ADVERSE DRUG REACTION 290 0.0032
702 DRUG ADMINISTRATION ERROR 99 0.0032
703 HEPATIC STEATOSIS 60 0.0032
704 UNRESPONSIVE TO STIMULI 83 0.0032
705 BLOOD TEST ABNORMAL 45 0.0032
706 ACUTE KIDNEY INJURY 488 0.0032
707 HEMIPARESIS 54 0.0032
708 ARTERIOSCLEROSIS 30 0.0032
709 BLOOD CREATININE INCREASED 208 0.0032
710 BLOOD PRESSURE DECREASED 211 0.0032
711 SKIN HAEMORRHAGE 47 0.0032
712 PULMONARY OEDEMA 142 0.0032
713 GLAUCOMA 61 0.0032
714 SPUTUM DISCOLOURED 30 0.0032
715 HEART RATE DECREASED 111 0.0032
716 SEPSIS 352 0.0032
717 HEPATOMEGALY 31 0.0032
718 ABSCESS 50 0.0031
719 EYE DISORDER 103 0.0031
720 CHOKING 61 0.0031
721 CONDITION AGGRAVATED 949 0.0031
722 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 53 0.0031
723 BLOOD PRESSURE ABNORMAL 62 0.0031
724 INTESTINAL PERFORATION 35 0.0031
725 COMPLICATION ASSOCIATED WITH DEVICE 45 0.0031
726 SYNCOPE 310 0.0031
727 WITHDRAWAL SYNDROME 130 0.0031
728 LEUKOCYTOSIS 56 0.0031
729 POST PROCEDURAL HAEMORRHAGE 36 0.0031
730 RESTLESSNESS 113 0.0031
731 HALLUCINATION, AUDITORY 49 0.0031
732 BLOOD GLUCOSE DECREASED 148 0.0031
733 ABNORMAL BEHAVIOUR 122 0.0031
734 OBESITY 49 0.0031
735 PSYCHOMOTOR HYPERACTIVITY 51 0.0031
736 GENERALISED OEDEMA 38 0.0031
737 PHARYNGITIS 38 0.0031
738 SPINAL DISORDER 29 0.0031
739 APPLICATION SITE RASH 42 0.0031
740 DYSKINESIA 124 0.0030
741 HAEMATOMA 79 0.0030
742 TUBULOINTERSTITIAL NEPHRITIS 57 0.0030
743 EUPHORIC MOOD 31 0.0030
744 DEAFNESS 79 0.0030
745 OESOPHAGITIS 33 0.0030
746 AGITATION 221 0.0030
747 CORONARY ARTERY DISEASE 91 0.0030
748 ALANINE AMINOTRANSFERASE INCREASED 184 0.0030
749 RENAL INJURY 89 0.0030
750 ASCITES 88 0.0030
751 SPINAL PAIN 35 0.0030
752 SKIN CANCER 64 0.0030
753 INCORRECT PRODUCT STORAGE 39 0.0030
754 EJECTION FRACTION DECREASED 46 0.0030
755 INFECTION 428 0.0030
756 ULCER 47 0.0030
757 NO THERAPEUTIC RESPONSE 36 0.0029
758 IMMUNODEFICIENCY 44 0.0029
759 GASTROENTERITIS 43 0.0029
760 EYELID OEDEMA 34 0.0029
761 BLOOD GLUCOSE FLUCTUATION 32 0.0029
762 OXYGEN SATURATION DECREASED 164 0.0029
763 CANDIDA INFECTION 49 0.0029
764 HYPOTENSION 581 0.0029
765 HYPOMAGNESAEMIA 40 0.0029
766 DEVICE MALFUNCTION 201 0.0029
767 DEVICE RELATED INFECTION 44 0.0029
768 EYELID PTOSIS 29 0.0029
769 INFUSION RELATED REACTION 189 0.0028
770 INTENTIONAL PRODUCT MISUSE 249 0.0028
771 PULMONARY THROMBOSIS 31 0.0028
772 MALAISE 1245 0.0028
773 PANCREATITIS 150 0.0028
774 DEMENTIA 79 0.0028
775 AGGRESSION 141 0.0028
776 MELAENA 62 0.0028
777 SINUS TACHYCARDIA 40 0.0028
778 FEMUR FRACTURE 87 0.0028
779 LIMB INJURY 76 0.0028
780 LOSS OF CONSCIOUSNESS 358 0.0028
781 DISEASE PROGRESSION 330 0.0028
782 IMPAIRED GASTRIC EMPTYING 38 0.0028
783 CONVULSION 159 0.0028
784 PETECHIAE 29 0.0028
785 SKIN REACTION 39 0.0028
786 OCULAR DISCOMFORT 31 0.0028
787 MOUTH ULCERATION 58 0.0027
788 INFLAMMATION 142 0.0027
789 ASTHMA 310 0.0027
790 TOOTH EXTRACTION 34 0.0027
791 MYDRIASIS 35 0.0027
792 EMOTIONAL DISORDER 84 0.0027
793 PNEUMONIA ASPIRATION 68 0.0027
794 GASTRITIS 71 0.0027
795 DEVICE EXPULSION 174 0.0027
796 PNEUMONITIS 73 0.0027
797 DIALYSIS 38 0.0027
798 FEEDING DISORDER 54 0.0027
799 SKIN LESION 73 0.0027
800 PNEUMOTHORAX 42 0.0026
801 PREGNANCY 53 0.0026
802 ECONOMIC PROBLEM 40 0.0026
803 INFUSION SITE PAIN 34 0.0026
804 DEVICE ISSUE 236 0.0026
805 INJECTION SITE HAEMATOMA 38 0.0026
806 OCULAR HYPERAEMIA 124 0.0026
807 HYPOKALAEMIA 120 0.0026
808 PANCYTOPENIA 145 0.0026
809 EYE PRURITUS 87 0.0026
810 HYPONATRAEMIA 145 0.0026
811 PALLOR 70 0.0026
812 PROCEDURAL PAIN 71 0.0026
813 CARDIAC DISORDER 239 0.0026
814 BLOOD GLUCOSE INCREASED 479 0.0025
815 RESPIRATORY DISORDER 76 0.0025
816 RESPIRATORY FAILURE 185 0.0025
817 MEDICATION ERROR 141 0.0025
818 PANCREATITIS ACUTE 57 0.0025
819 GASTROINTESTINAL DISORDER 227 0.0025
820 MUSCULOSKELETAL DISORDER 48 0.0025
821 UNDERDOSE 184 0.0025
822 SEIZURE 290 0.0025
823 NEUTROPHIL COUNT DECREASED 102 0.0025
824 ELECTROLYTE IMBALANCE 29 0.0025
825 CYTOKINE RELEASE SYNDROME 50 0.0025
826 EYE IRRITATION 142 0.0025
827 DERMATITIS ALLERGIC 31 0.0025
828 DRUG INEFFECTIVE 3243 0.0025
829 HAEMATEMESIS 62 0.0024
830 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 57 0.0024
831 ANGINA PECTORIS 70 0.0024
832 GENERAL PHYSICAL HEALTH DETERIORATION 282 0.0024
833 THROMBOCYTOPENIA 271 0.0024
834 INTENTIONAL PRODUCT USE ISSUE 212 0.0024
835 RENAL DISORDER 112 0.0024
836 LYMPHOMA 37 0.0024
837 HYPOACUSIS 103 0.0024
838 MENTAL DISORDER 104 0.0024
839 ENCEPHALOPATHY 58 0.0024
840 INJECTION SITE IRRITATION 30 0.0024
841 DRUG DISPENSING ERROR 36 0.0024
842 LUNG DISORDER 115 0.0023
843 HYPERKALAEMIA 82 0.0023
844 APPLICATION SITE IRRITATION 29 0.0023
845 PRODUCT PHYSICAL ISSUE 47 0.0023
846 ANHEDONIA 61 0.0023
847 ADRENAL INSUFFICIENCY 28 0.0023
848 ARRHYTHMIA 109 0.0023
849 PLATELET COUNT INCREASED 30 0.0023
850 DRUG PRESCRIBING ERROR 44 0.0023
851 COLON CANCER 34 0.0023
852 HAEMORRHAGE INTRACRANIAL 34 0.0023
853 ACUTE MYOCARDIAL INFARCTION 67 0.0023
854 CEREBRAL HAEMORRHAGE 81 0.0023
855 HAEMORRHAGE 236 0.0023
856 LIVER DISORDER 100 0.0023
857 PARALYSIS 32 0.0022
858 GLYCOSYLATED HAEMOGLOBIN INCREASED 56 0.0022
859 ORAL HERPES 43 0.0022
860 CEREBROVASCULAR ACCIDENT 371 0.0022
861 INCORRECT DOSE ADMINISTERED 499 0.0022
862 DRUG INTOLERANCE 211 0.0022
863 HYPERGLYCAEMIA 79 0.0022
864 SEPTIC SHOCK 94 0.0022
865 BLOOD PRESSURE SYSTOLIC INCREASED 42 0.0022
866 HYPERTHYROIDISM 31 0.0021
867 MULTI-ORGAN FAILURE 37 0.0021
868 MULTIPLE FRACTURES 35 0.0021
869 VENTRICULAR TACHYCARDIA 35 0.0021
870 ACUTE MYELOID LEUKAEMIA 33 0.0021
871 SEDATION 55 0.0021
872 PSYCHOTIC DISORDER 62 0.0021
873 PRODUCT USE ISSUE 391 0.0021
874 TOOTH LOSS 43 0.0021
875 EXTRA DOSE ADMINISTERED 84 0.0021
876 GENERALISED TONIC-CLONIC SEIZURE 34 0.0021
877 AMENORRHOEA 36 0.0021
878 CONJUNCTIVITIS 38 0.0020
879 METASTASES TO LIVER 36 0.0020
880 JAUNDICE 55 0.0020
881 BONE DENSITY DECREASED 64 0.0020
882 DEVICE FAILURE 31 0.0020
883 CYANOSIS 32 0.0020
884 EXPIRED PRODUCT ADMINISTERED 67 0.0020
885 NEUTROPENIA 274 0.0020
886 BONE LOSS 30 0.0020
887 HOSPITALISATION 304 0.0020
888 BRONCHOSPASM 28 0.0020
889 ILL-DEFINED DISORDER 119 0.0020
890 THERAPY NON-RESPONDER 88 0.0020
891 DIABETES MELLITUS 147 0.0019
892 RESPIRATORY DISTRESS 53 0.0019
893 THERAPY INTERRUPTED 137 0.0019
894 INTENTIONAL DRUG MISUSE 40 0.0019
895 SURGERY 111 0.0019
896 STEVENS-JOHNSON SYNDROME 42 0.0019
897 MYOCARDIAL INFARCTION 329 0.0019
898 HYPOGLYCAEMIA 91 0.0019
899 SEROTONIN SYNDROME 36 0.0019
900 ABORTION SPONTANEOUS 75 0.0019
901 FEBRILE NEUTROPENIA 124 0.0019
902 FACE OEDEMA 31 0.0018
903 BRADYCARDIA 97 0.0018
904 RENAL IMPAIRMENT 153 0.0018
905 LYMPHOCYTE COUNT DECREASED 32 0.0018
906 TREATMENT NONCOMPLIANCE 98 0.0018
907 DRUG INTERACTION 281 0.0018
908 DEPRESSED LEVEL OF CONSCIOUSNESS 70 0.0018
909 BLOOD LACTATE DEHYDROGENASE INCREASED 28 0.0018
910 BLOOD CREATINE PHOSPHOKINASE INCREASED 50 0.0017
911 MUCOSAL INFLAMMATION 45 0.0017
912 LOWER RESPIRATORY TRACT INFECTION 78 0.0017
913 ADVERSE EVENT 157 0.0017
914 MALIGNANT NEOPLASM PROGRESSION 174 0.0017
915 DRUG LEVEL INCREASED 28 0.0017
916 HEPATITIS 43 0.0017
917 BLOOD GLUCOSE ABNORMAL 31 0.0017
918 INJURY ASSOCIATED WITH DEVICE 34 0.0017
919 DRUG EXPOSURE DURING PREGNANCY 56 0.0016
920 NERVOUS SYSTEM DISORDER 51 0.0016
921 METABOLIC ACIDOSIS 52 0.0016
922 INCORRECT ROUTE OF DRUG ADMINISTRATION 58 0.0016
923 THERAPEUTIC RESPONSE DECREASED 98 0.0016
924 CONTRAINDICATED PRODUCT ADMINISTERED 48 0.0016
925 DIABETES MELLITUS INADEQUATE CONTROL 28 0.0016
926 NEEDLE ISSUE 46 0.0016
927 CARDIAC ARREST 130 0.0016
928 TRANSAMINASES INCREASED 35 0.0016
929 RASH MACULO-PAPULAR 35 0.0016
930 DRUG WITHDRAWAL SYNDROME 137 0.0016
931 CARDIO-RESPIRATORY ARREST 65 0.0016
932 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 85 0.0015
933 PERITONITIS 31 0.0015
934 INCORRECT DOSE ADMINISTERED BY DEVICE 39 0.0015
935 ELECTROCARDIOGRAM QT PROLONGED 53 0.0015
936 EXPOSURE DURING PREGNANCY 91 0.0015
937 DIABETIC KETOACIDOSIS 35 0.0015
938 LEUKOPENIA 72 0.0014
939 PRODUCT ADHESION ISSUE 51 0.0014
940 HEPATIC FAILURE 43 0.0014
941 OFF LABEL USE 1248 0.0014
942 EMOTIONAL DISTRESS 172 0.0014
943 OSTEONECROSIS OF JAW 35 0.0014
944 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 47 0.0014
945 THERAPEUTIC PRODUCT EFFECT DECREASED 62 0.0014
946 CARDIAC FAILURE 111 0.0014
947 ECZEMA 72 0.0014
948 ANAPHYLACTIC REACTION 76 0.0014
949 LUNG NEOPLASM MALIGNANT 56 0.0014
950 ACCIDENTAL OVERDOSE 48 0.0013
951 ANGIOEDEMA 55 0.0012
952 RESPIRATORY ARREST 34 0.0012
953 BLINDNESS 50 0.0012
954 DISEASE RECURRENCE 58 0.0012
955 BREAST CANCER 112 0.0012
956 DEATH 1032 0.0012
957 INTENTIONAL DOSE OMISSION 34 0.0012
958 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 241 0.0012
959 OSTEONECROSIS 39 0.0012
960 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 210 0.0012
961 RHABDOMYOLYSIS 48 0.0011
962 CEREBRAL INFARCTION 28 0.0011
963 PRODUCT COMPLAINT 29 0.0011
964 TARDIVE DYSKINESIA 31 0.0011
965 LACTIC ACIDOSIS 35 0.0011
966 OVERDOSE 233 0.0011
967 EPILEPSY 33 0.0011
968 COMA 50 0.0010
969 DEVICE LEAKAGE 44 0.0010
970 THERAPEUTIC RESPONSE SHORTENED 33 0.0010
971 NEOPLASM MALIGNANT 65 0.0010
972 DEVICE BREAKAGE 39 0.0010
973 INTERSTITIAL LUNG DISEASE 46 0.0009
974 NEOPLASM PROGRESSION 33 0.0009
975 MATERNAL EXPOSURE DURING PREGNANCY 82 0.0009
976 PROSTATE CANCER 68 0.0008
977 PRODUCT USE IN UNAPPROVED INDICATION 201 0.0008
978 TREATMENT FAILURE 67 0.0008
979 COVID-19 131 0.0007
980 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 53 0.0007
981 TOXICITY TO VARIOUS AGENTS 124 0.0007
982 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 32 0.0007
983 SUICIDE ATTEMPT 40 0.0007
984 PRODUCT DOSE OMISSION ISSUE 175 0.0006
985 DEVICE DIFFICULT TO USE 32 0.0005
986 ACCIDENTAL EXPOSURE TO PRODUCT 46 0.0004
987 ILLNESS 43 0.0004
988 NO ADVERSE EVENT 73 0.0004
989 COMPLETED SUICIDE 30 0.0004
990 FOETAL EXPOSURE DURING PREGNANCY 28 0.0003
991 DRUG DEPENDENCE 52 0.0003